Impulse News

Impulse Dynamics announced the first enrollment in the IMPULSE-HF European Randomized Efficacy Study

October 2014 – Impulse Dynamics announced the first enrollment to the IMPULSE-HF European randomized controlled efficacy study in Europe at the Karolinska Institute, Stockholm, Sweden. “We are very happy to enroll the first patient in the IMPULSE-HF study and we look forward to gain experience with the CCM therapy in Sweden” said Prof. Cecilia Linde […]

Mehr dazu

Impulse Dynamics announced the first implantation of the Optimizer IVs device in the Czech Republic

Impulse Dynamics announced the first implantation of the Optimizer IVs device in the Czech Republic earlier this summer. The implantation took place at the Na Homolce Hospital in Prague (Czech Republic) by Prof. Petr Neuzil, M.D., Head of cardiology. The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF). […]

Mehr dazu

Impulse Dynamics Announces Enrollment of the First Subject in the FIX-HF-5C Confirmatory Study of the Optimizer™ IVs System in NYHA Class III/IV Heart Failure Patients

Orangeburg, NY – August 4, 2014 Impulse Dynamics (USA), Inc. announced today that the first US implant of the Optimizer™ IVs System in the FIX-HF-5C Confirmatory Study was performed by Stanislav Weiner, M.D. at Mother Frances Hospital in Tyler, Texas. The study is designed to evaluate the safety and efficacy of the Optimizer™ IVs System […]

Mehr dazu

Impulse Dynamics Announces Enrollment of the First Subject in the FIX-HF-5C Confirmatory Study of the Optimizer IVs System in NYHA Class III/IV Heart Failure Patients

Orangeburg, NY – July 28, 2014 – Impulse Dynamics (USA), Inc. announced today that enrollment has commenced in FIX-HF-5C Confirmatory Study. The study is designed to evaluate the safety and efficacy of the Optimizer™ IVs System in moderate to severe heart failure patients with an LVEF of 25-45% and a QRS <130ms.

Mehr dazu

Impulse Dynamics announced the first implantation of the Optimizer IVs device in Hungary

Impulse Dynamics announced today the first implantation of it Optimizer IVs device in Hungary.  The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF).  The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses. The implantation took place at the Semmelweis University by […]

Mehr dazu